Adjuvant chemotherapy in endometrial cancer César Gómez-RaposoMaría Merino SalvadorEnrique Casado Saenz Review Article 16 January 2020 Pages: 477 - 486
Population pharmacokinetic modeling of PF-06439535 (a bevacizumab biosimilar) and reference bevacizumab (Avastin®) in patients with advanced non-squamous non-small cell lung cancer Cheryl S. W. LiKevin SweeneyCarol Cronenberger Original Article Open access 26 November 2019 Pages: 487 - 499
Characterization of infections and hypogammaglobulinemia treated with the combination of pertuzumab and trastuzumab Joanne E. MortimerLaura KruperYuan Yuan Original Article Open access 22 October 2019 Pages: 501 - 507
A retrospective study of the correlation of in vitro chemosensitivity using ATP-TCA with patient clinical outcomes in acute myeloid leukemia Fan XiaSheng MaLiyan Miao Original Article 25 October 2019 Pages: 509 - 515
Interstitial lung disease in advanced pancreatic ductal adenocarcinoma patients treated with gemcitabine and nab-paclitaxel combination therapy: a retrospective analysis Hiroki IrieRei SuzukiHiromasa Ohira Original Article 05 November 2019 Pages: 517 - 523
Blood mRNA expression of REV3L and TYMS as potential predictive biomarkers from platinum-based chemotherapy plus pemetrexed in non-small cell lung cancer patients M. Teresa Agulló-OrtuñoInmaculada García-RuizJuan A. Nuñez Original Article 12 December 2019 Pages: 525 - 535
Preoperative chemoradiotherapy using gemcitabine for pancreatic ductal adenocarcinoma in patients with impaired renal function Yoshito TomimaruHidetoshi EguchiYuichiro Doki Original Article 13 December 2019 Pages: 537 - 545
The influence of single-nucleotide polymorphisms on overall survival and toxicity in cabazitaxel-treated patients with metastatic castration-resistant prostate cancer Bodine P. S. BelderbosMirjam de WithSander Bins Original Article 01 January 2020 Pages: 547 - 553
A randomized, double-blind, single-dose study to evaluate the biosimilarity of QL1101 with bevacizumab in healthy male subjects Ya-nan LiuJie HuangGuo-ping Yang Original Article Open access 06 January 2020 Pages: 555 - 562
Cardioprotective effects of dapsone against doxorubicin-induced cardiotoxicity in rats Mohammad SheibaniSadaf NezamoleslamiAhmad Reza Dehpour Original Article 08 January 2020 Pages: 563 - 571
The use of Trichomonas vaginalis purine nucleoside phosphorylase to activate fludarabine in the treatment of solid tumors William B. ParkerPaula W. AllanEric J. Sorscher Original Article 08 January 2020 Pages: 573 - 583
Formulae recently proposed to estimate renal glomerular filtration rate improve the prediction of carboplatin clearance Melanie White-KoningMarie Noëlle PaludettoFlorent Puisset Original Article 09 January 2020 Pages: 585 - 592
A Phase I dose-escalation, pharmacokinetics and food-effect study of oral donafenib in patients with advanced solid tumours Xiaoyu LiMeng QiuLi Zheng Original Article 01 February 2020 Pages: 593 - 604
Evaluation of gefitinib systemic exposure in EGFR-mutated non-small cell lung cancer patients with gefitinib-induced severe hepatotoxicity Takahisa KawamuraChiyo K. ImamuraYusuke Tanigawara Original Article 10 February 2020 Pages: 605 - 614
Relationship between vemurafenib plasma concentrations and survival outcomes in patients with advanced melanoma Ganessan KichenadasseJim Henry HughesMichael J. Sorich Short Communication 30 November 2019 Pages: 615 - 620
Evaluation of the bioequivalence and food effect on the bioavailability of CC-486 (oral azacitidine) tablets in adult patients with cancer Hani M. BabikerMohammed MilhemThai Ho Short Communication Open access 08 February 2020 Pages: 621 - 626
